Retratamento com surfactante em prematuros de muito baixo peso: preditores de risco e sua influência nos resultados neonatais

Ferri, Walusa Assad Gonçalves; Silva, Adriana Carnevale da; Sacramento, Eliana Motta Fernandes; Calixto, Cristina; Aragon, Davi Casale; Caldas, Jamil Pedro de Siqueira.
Rev. Paul. Pediatr. (Ed. Port., Online) ; 39: e2019360, 2021. tab
Artigo em Inglês, Português | LILACS, SES-SP | ID: biblio-1136743

Documentos relacionados

  1. RETREATMENT WITH SURFACTANT IN VERY LOW BIRTH WEIGHT PRETERM INFANTS: RISK PREDICTORS AND THEIR INFLUENCE ON NEONATAL OUTCOMES.
  2. Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome: The OPTIMIST-A Randomized Clinical Trial.
  3. Evaluation of a respiratory care protocol including less invasive surfactant administration in preterm infants.
  4. A Multicentered Randomized Study on Early versus Rescue Calsurf Administration for the Treatment of Respiratory Distress Syndrome in Preterm Infants.
  5. Two-Year Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants: Follow-Up of the OPTIMIST-A Randomized Clinical Trial.
  6. Pharmacoeconomic evaluation of different doses of Curosurf for treating neonatal acute respiratory distress syndrome.
  7. Underdosing of Surfactant for Preterm Babies with Respiratory Distress Syndrome in Clinical Practice: A Retrospective Cohort Study.
  8. Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial.
  9. Nebulized Poractant Alfa Reduces the Risk of Respiratory Failure at 72 Hours in Spontaneously Breathing Surfactant-Deficient Newborn Piglets.
  10. Can surfactants affect mortality and morbidity in term infants with respiratory failure?